KeyBank National Association’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $16.1M | Buy |
127,699
+152
| +0.1% | +$20K | 0.05% | 209 |
|
|
2026
Q1 | $17.8M | Buy |
127,547
+12,268
| +11% | +$1.72M | 0.06% | 191 |
|
|
2025
Q4 | $14.1M | Buy |
115,279
+7,503
| +7% | +$912K | 0.05% | 205 |
|
|
2025
Q3 | $12M | Buy |
107,776
+519
| +0.5% | +$59K | 0.04% | 215 |
|
|
2025
Q2 | $11.9M | Buy |
107,257
+1,648
| +2% | +$175K | 0.04% | 224 |
|
|
2025
Q1 | $11.8M | Sell |
105,609
-922
| -0.9% | -$95.1K | 0.05% | 215 |
|
|
2024
Q4 | $9.84M | Sell |
106,531
-9,263
| -8% | -$834K | 0.04% | 231 |
|
|
2024
Q3 | $9.71M | Sell |
115,794
-176
| -0.2% | -$13.4K | 0.04% | 236 |
|
|
2024
Q2 | $7.96M | Sell |
115,970
-5,522
| -5% | -$369K | 0.03% | 239 |
|
|
2024
Q1 | $8.9M | Buy |
121,492
+5,364
| +5% | +$412K | 0.04% | 231 |
|
|
2023
Q4 | $9.41M | Buy |
116,128
+11,813
| +11% | +$919K | 0.04% | 226 |
|
|
2023
Q3 | $7.82M | Sell |
104,315
-2,842
| -3% | -$219K | 0.04% | 229 |
|
|
2023
Q2 | $8.26M | Sell |
107,157
-1,215
| -1% | -$96.9K | 0.04% | 225 |
|
|
2023
Q1 | $8.99M | Sell |
108,372
-355
| -0.3% | -$29.4K | 0.04% | 215 |
|
|
2022
Q4 | $9.33M | Buy |
108,727
+4,617
| +4% | +$366K | 0.05% | 205 |
|
|
2022
Q3 | $6.42M | Sell |
104,110
-3,709
| -3% | -$234K | 0.03% | 230 |
|
|
2022
Q2 | $6.66M | Sell |
107,819
-1,255
| -1% | -$77.7K | 0.03% | 231 |
|
|
2022
Q1 | $6.48M | Sell |
109,074
-4,585
| -4% | -$293K | 0.03% | 242 |
|
|
2021
Q4 | $8.25M | Sell |
113,659
-6,903
| -6% | -$475K | 0.03% | 228 |
|
|
2021
Q3 | $8.42M | Sell |
120,562
-4,578
| -4% | -$322K | 0.04% | 223 |
|
|
2021
Q2 | $8.62M | Sell |
125,140
-10,703
| -8% | -$715K | 0.04% | 223 |
|
|
2021
Q1 | $8.78M | Sell |
135,843
-9,909
| -7% | -$639K | 0.04% | 221 |
|
|
2020
Q4 | $8.49M | Sell |
145,752
-13,857
| -9% | -$836K | 0.04% | 213 |
|
|
2020
Q3 | $10.1M | Sell |
159,609
-9,572
| -6% | -$664K | 0.05% | 190 |
|
|
2020
Q2 | $13M | Sell |
169,181
-805
| -0.5% | -$61.7K | 0.08% | 167 |
|
|
2020
Q1 | $12.7M | Sell |
169,986
-12,557
| -7% | -$868K | 0.08% | 157 |
|
|
2019
Q4 | $11.9M | Sell |
182,543
-21,533
| -11% | -$1.4M | 0.06% | 190 |
|
|
2019
Q3 | $12.9M | Sell |
204,076
-26,511
| -11% | -$1.73M | 0.07% | 180 |
|
|
2019
Q2 | $15.6M | Sell |
230,587
-42,045
| -15% | -$2.77M | 0.09% | 169 |
|
|
2019
Q1 | $17.7M | Sell |
272,632
-60,780
| -18% | -$4.04M | 0.11% | 159 |
|
|
2018
Q4 | $20.9M | Sell |
333,412
-176,705
| -35% | -$12.4M | 0.14% | 134 |
|
|
2018
Q3 | $39.4M | Buy |
510,117
+7,584
| +2% | +$573K | 0.22% | 102 |
|
|
2018
Q2 | $35.6M | Sell |
502,533
-949
| -0.2% | -$67K | 0.21% | 103 |
|
|
2018
Q1 | $38M | Buy |
503,482
+8,941
| +2% | +$711K | 0.22% | 99 |
|
|
2017
Q4 | $35.4M | Sell |
494,541
-40,294
| -8% | -$3.06M | 0.2% | 106 |
|
|
2017
Q3 | $43.3M | Sell |
534,835
-6,913
| -1% | -$529K | 0.26% | 90 |
|
|
2017
Q2 | $38.3M | Sell |
541,748
-59,637
| -10% | -$3.97M | 0.23% | 100 |
|
|
2017
Q1 | $40.8M | Sell |
601,385
-59,387
| -9% | -$4.18M | 0.25% | 96 |
|
|
2016
Q4 | $47.3M | Sell |
660,772
-57,221
| -8% | -$4.25M | 0.3% | 84 |
|
|
2016
Q3 | $56.8M | Sell |
717,993
-2,711
| -0.4% | -$220K | 0.36% | 71 |
|
|
2016
Q2 | $60.1M | Sell |
720,704
-1,091
| -0.2% | -$96.8K | 0.39% | 65 |
|
|
2016
Q1 | $66.3M | Buy |
721,795
+11,705
| +2% | +$1.06M | 0.44% | 58 |
|
|
2015
Q4 | $71.9M | Buy |
710,090
+19,229
| +3% | +$2M | 0.48% | 51 |
|
|
2015
Q3 | $67.8M | Buy |
690,861
+32,427
| +5% | +$3.6M | 0.48% | 50 |
|
|
2015
Q2 | $77.1M | Buy |
658,434
+16,310
| +3% | +$1.78M | 0.51% | 47 |
|
|
2015
Q1 | $63M | Buy |
642,124
+105,930
| +20% | +$10.8M | 0.41% | 61 |
|
|
2014
Q4 | $50.5M | Buy |
536,194
+22,986
| +4% | +$2.38M | 0.33% | 82 |
|
|
2014
Q3 | $54.6M | Buy |
513,208
+7,916
| +2% | +$775K | 0.37% | 67 |
|
|
2014
Q2 | $41.9M | Sell |
505,292
-43,313
| -8% | -$3.37M | 0.28% | 91 |
|
|
2014
Q1 | $38.9M | Buy |
548,605
+34,564
| +7% | +$2.71M | 0.3% | 91 |
|
|
2013
Q4 | $38.6M | Buy |
514,041
+6,993
| +1% | +$487K | 0.25% | 94 |
|
|
2013
Q3 | $31.9M | Sell |
507,048
-956,213
| -65% | -$57.1M | 0.22% | 98 |
|
|
2013
Q2 | $75.5M | Buy |
+1,463,261
| New | +$76.3M | 0.28% | 93 |
|
Other funds holding GILD
KeyBank National Association's GILD Position: Q2 2026 in Review
KeyBank National Association increased its Gilead Sciences (GILD) stake by 0.12% in Q2 2026, buying an estimated $20K and bringing the position to 127,699 shares worth $16.1M. The position accounts for 0.05% of the portfolio, ranked #209.
KeyBank National Association first reported a position in GILD in Q2 2013 and has held it in 53 quarters since. The position peaked at $77.1M in Q2 2015. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- KeyBank National Association held 127,699 shares of Gilead Sciences worth $16.1M as of Q2 2026.
- KeyBank National Association bought 152 Gilead Sciences shares in Q2 2026, an estimated $20K.
- Gilead Sciences made up 0.05% of KeyBank National Association's portfolio in Q2 2026, its #209 holding.
- KeyBank National Association first reported a position in Gilead Sciences in Q2 2013 and has held it in 53 quarters since.
- KeyBank National Association's Gilead Sciences position peaked at $77.1M in Q2 2015.
- 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on KeyBank National Association's 13F filing for Q2 2026, filed 28 Jul 2026.